Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com


Buscar en contenido


jueves, 20 de septiembre de 2012

Embolismo pulmonar

AHA Scientific Statement
Management of Massive and Submassive Pulmonary
Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic
Thromboembolic Pulmonary Hypertension
(A Scientific Statement From the American Heart Association)
Jaff M et al. Circulation. 2011;123:1788-1830
"Venous thromboembolism (VTE) is responsible for the hospitalization of 250000 Americans annually and represents a significant risk for morbidity and mortality. Despite the publication of evidence-based clinical practice guidelines to aid in the management of VTE in its acute and chronic forms, the clinician is frequently confronted with manifestations of VTE for which data are sparse and optimal management is unclear. In particular, the optimal use of advanced therapies for acute VTE, including thrombolysis and catheter-based therapies, remains uncertain. This report addresses the management of massive and submassive pulmonary embolism (PE), iliofemoral deep vein thrombosis (IFDVT), and chronic thromboembolic pulmonary hypertension (CTEPH)..."

Simplified PESI 

(Pulmonary Embolism Severity Index)